Tag Archives: Parliament

New: All-Party Parliamentary Group for Psychology (BPS)

Posted on July 12, 2017 by Dementia and Elderly Care News

Summary The purpose of the All-Party Parliamentary Group for Psychology is to “raise awareness amongst parliamentarians and policymakers of the importance and relevance of psychology”. This new APPG has the aim of maximising the impact of psychology for greater public … Continue reading →

Posted in In the News, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Person-Centred Care, Quick Insights, UK, Universal Interest | Tagged Ageing Policy in the UK, Ageing Population, All Party Parliamentary Group(s), BPS All Party Parliamentary Group for Psychology, British Psychological Society (BPS), Dementia Policy, Dr Lisa Morrison-Coulthard: Policy Director at British Psychological Society, Lisa Cameron MP: Chair of All Party Parliamentary Group for Psychology, Parliament, Parliamentarians, Social Policy and Society, Societal Challenges, UK Parliament | Leave a comment

Unresolved Issues of Means-Testing in the Payment For Social Care: a Recent History of the Dementia Tax (House of Commons Library)

Posted on June 24, 2017 by Dementia and Elderly Care News

Summary A recent House of Commons Library briefing paper presents an overview of policy proposals and actual policies, from different Governments since 1997, concerning for how individuals with assets must pay for social care. Unlike health services provided by the NHS, social … Continue reading →

Posted in Commissioning, Community Care, For Carers (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, Management of Condition, National, Non-Pharmacological Treatments, Person-Centred Care, Quick Insights, Scotland, Standards, Statistics, UK, Universal Interest | Tagged Adult Social Care, Adult Social Care Funding, Adult Social Care in England, Adult Social Care Services, Ageing and Dementia, Ageing and Society, Ageing Policy in the UK, Ageing Population, Barriers to Integration: NHS Services Free Versus Means-Tested Social Care, Care Costs: Cap and Means Test, Care Funding, Care Home Costs, Care Home Fees, Care Tax (So-Called Dementia Tax), Caring and Family Finances, Catastrophic Care Costs, Changes Since UK Devolution, Commission on the Funding of Care and Support (2012 Report), Competition and Market Authority (CMA), Conservative Government 2017 U-Turn Over Cap on Social Care Costs, Conservative Manifesto (2017), Conservative Manifesto (2017): Forward Together – Our Plan for a Stronger Britain and a Prosperous Future, Conservative Manifesto on Social Care (2017), Conservative Party’s 2017 Election Manifesto, Cost of Social Care for Older People, Dementia Tax, Dementia Tax (Alzheimer's Society), Devolution, Devolved Decision-Making, Dilnot Commission Recommendations, Dilnot Commission Report on Funding of Care and Support, Financial Constraints, Financial Context, Financial Issues, Financial Planning, Four-Year Cap on Paying Social Care Charges (Historical Unadopted Policy Proposal), Free Personal Care in Scotland, Funding of Care and Support (Dilnot Commission), Health and Social Care Services, Home and Community Care Services, Home Care, Home Care Services, House of Commons, House of Commons Library, House of Commons Library Briefing Paper CBP-8000, Labour Government’s 2010 Proposal for Free Social Care (Unfulfilled), Labour Governments and Conservative Governments: Surprising Historical Commonalities, Long-Term Care (LTC), Long-Term Care and Support, Long-Term Conditions (LTCs), Means Test, National Care Service (Historical Proposals), Neurodegenerative Diseases, Neurodegenerative Disorders, Parliament, Payment For Social Care: a Brief History of Policy (House of Commons Library), Professor Sir Stuart Sutherland (Royal Commission on Long-Term Care for the Elderly), Property and Capital: Means-Test (Care Home Residents), Property and Capital: Means-Test (Home Care Proposals 2017), Queen's Speech 2017, Royal Commission on Long Term Care, Royal Commission on Long Term Care for Older People, Royal Commission on Long Term Care of Older People, Scottish Executive, Securing Good Care for Older People (2006), Self-Funders, Self-Funders Cross-Subsidising Everyone Else, Self-Funders Cross-Subsidising Non-Savers, Self-Funders Subsidising the Social Care System, Self-Funding, Sir Andrew Dilnot, Sir Derek Wanless’s (2006) Report Proposing Partnership Funding for Social Care, Social Care Crisis, Social Care: Government Reviews and Policy Proposals on Paying For Care, Social Care: Timeline of Government Reviews and Policy Proposals re: Paying For Care, State Funded Social Care, Stealth Death Tax: Chargable Against Families' Property Assets, Stealth Taxes, Sustainability, Tariff Income, Theresa May Social Care U-Turn (2017), Tory Social Care Plans (2017), UK Parliament, Unreasonable Charges, Unreasonable Charging For Care (After Death), Upfront Costs, Upper and Lower Capital Limits of Means-Test, What is Classed as Capital: Means-Test | Leave a comment

Sustainability of Funding for NHS and Adult Social Care (House of Lords Select Committee)

Posted on April 10, 2017 by Dementia and Elderly Care News

Summary The House of Lords Select Committee on the Long-term Sustainability of the NHS has identified a culture of short-termism regarding the funding of NHS and adult social care. All governments have short-sightedly failed to plan effectively for the long-term, … Continue reading →

New Drugs for Dementia (POST Note PN 535)

Posted on August 29, 2016 by Dementia and Elderly Care News

Summary The Parliamentary Office of Science and Technology (POST) has produced a briefing outlining some of the challenges in developing new drugs for dementia, explained in the context of ongoing UK and international research programmes. There is an extensive bibliography, … Continue reading →

Posted in Alzheimer's Society, Alzheimer’s Research UK, Antipsychotics, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Models of Dementia Care, National, Pharmacological Treatments, Quick Insights, Statistics, UK, Universal Interest | Tagged Academic Institutes in the UK, Academy of Social Sciences, Aducanumab (Biogen), Alzheimer’s Association, Alzheimer’s Research UK’s Drug Discovery Alliance, Behavioural and Psychological Symptoms of Dementia (BPSD), Big Data, Big Data Funding and Research, Big Pharma, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, BPSD: Behavioral and Psychological Symptoms of Dementia, British Psychological Society (BPS), Co-ordination and Data Analytics, Cognitive Health in Ageing Register for Investigations, Collaborative Projects, Collaborative Research, Dementia Consortium, Dementia Risk Prevention, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), DPUK: Dementias Platform UK, Drug Discovery Alliance, Drug Licensing Approval, Drugs for BPSD, Drugs for Cognitive Symptoms of Cognitive Decline and Dementia, EAMS: Early Access to Medicines Scheme, Early Access to Medicines Scheme, Effective Non-Drug Interventions, Etanercept, European Prevention of Alzheimer's Dementia Consortium (EPAD), European Prevention of Alzheimer’s Dementia Consortium, Identification of People At Risk of Dementia, International Collaborations, International Programmes, International Research, Join Dementia Research, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, New Drugs for Dementia (POST Note PN 535), NIHR Clinical Research Network, Observations & Trials in Dementia Research, Parliament, Parliamentary Office of Science & Technology, Parliamentary Office of Science & Technology (POST), Participation in Research, Patient Access to New Drugs, Pharmaceutical Industry, Pioglitazone, POST: Parliamentary Office of Science & Technology, Pre-Symptomatic Diagnosis of Dementia, Preclinical Biomarkers and Dementia, Preclinical Indicators and Dementia, Prevention, Public Participation in Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Mapping, Research Networks, Solanezumab (Eli Lilly), Symptom-Modifying Drugs for Dementia, UK Dementia Research Institute, UK Parliament, UK Patient Recruitment Initiatives, Verubecestat (Merck), Well-Being and Health for People With Dementia (WHELD) Program | Leave a comment

Updated Official Statistics on Dementia Prevalence and Improvements to Dementia Diagnosis, Care and Research (House of Commons Library)

Posted on August 3, 2015 by Dementia and Elderly Care News

Summary This recently updated House of Commons Library briefing paper summarises the government’s, the NHS’s and other statutory bodies’ work to improve dementia diagnosis, care and support and research. This document presents statistics and maps on rates (and the expected … Continue reading →

Minimising CJD and vCJD Transmission Risks in Healthcare and Community Settings (Department of Health)

Posted on July 17, 2015 by Dementia and Elderly Care News

Summary The Advisory Committee on Dangerous Pathogens’ Transmissible Spongiform Encephalopathy (ACDP TSE) Risk Management Subgroup has released updated guidance which aims to minimise the risks of transmission of CJD and vCJD in healthcare and other public settings. Full Text Link … Continue reading →

Recommendations for Improving End-of-Life Care (BBC News / House of Commons Health Committee)

Posted on March 16, 2015 by Dementia and Elderly Care News

Summary The House of Commons Health Select Committee has issued a report which makes a range of suggestions for improving end-of-life care. Many people still die in hospital, rather than their preferred place of death. It is proposed that social … Continue reading →

Posted in BBC News, Commissioning, Community Care, End of Life Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, Management of Condition, National, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged Access to Palliative and End of Life Care, Access to Services, Access to Social Services, Advance Care Planning, Advance Care Planning (ACP), BBC Health News, Bereavement Support, Beyond the Liverpool Care Pathway, Care in the Community, Childhood Bereavement Network, Cicely Saunders Institute, Cicely Saunders Institute: Kings College London, Community Care Services, Community Resourcing, Community-Based Care, Community-Based Interventions, Community-Based Palliative Care Service, Community-Based Services, Community-Based Support, Costs of Lasting Power of Attorney (LPA), DNACPR, DNACPR Documentation, Do Not Attempt Cardiopulmonary Resuscitation Orders (DNACPR), Electronic Care Planning, Electronic Palliative Care Co-ordination Systems (EPaCCS), Eligibility Criteria for Social Care, End of Life Nursing (Community-Based), End-of-Life Care at Home, End-of-Life Care Delivered At Home, End-of-Life Care Pathways, End-of-Life Support, Equal Access to Care, Equality of Access, Fair Access to Care Services, Fast Track Pathway, Five Priorities for Care, Former Minister of Care Services Norman Lamb, Free Social Care Towards End-of-Life, House of Commons, House of Commons Health Committee, House of Commons Health Select Committee, Integrated and Community-Based Care, James Lind Alliance (JLA), LACDP: Leadership Alliance for the Care of Dying People, Lasting Power of Attorney (LPA), Leadership, Leadership Alliance for the Care of Dying People (LACDP), Local Leadership, Macmillan Cancer Support, National Council for Palliative Care (NCPC), National Institute for Health and Care Excellence (NICE)’s Quality Standard on End of Life Care, NHS Continuing Healthcare Fast Track Pathway, Norman Lamb MP (Former Minister of State for Care and Support), Palliative and End of Life Care, Palliative and End of Life Care Priority Setting Partnership, Palliative and End-of-Life Care at Home, Palliative and End-of-Life Care in Hospices, Palliative Care Funding Review, Palliative Care Funding Review (PCFR), Parliament, Parliamentarians, Preferred Place of Death, Quality of End of Life Care in Different Settings, Research into Palliative and End of Life Care, Sarah Wollaston: Chair of the House of Commons Health Select Committee, Specialist Palliative Care Services (SPC), UK Parliament, Workforce Planning and Development | Leave a comment

Outline of Government’s Work to Improve Dementia Diagnosis, Care and Research 2015 (House of Commons Library)

Posted on February 28, 2015 by Dementia and Elderly Care News

Summary Coinciding with publication of the Prime Minister’s Challenge on Dementia 2020, this House of Commons Library Standard Note discusses the Government’s objectives for the next five years, in relation to Government’s, NHS’s and other statutory bodies’ efforts to improve … Continue reading →

Risks of Variant Creutzfeldt-Jakob Disease: UK Blood Safety (Department of Health)

Posted on October 24, 2014 by Dementia and Elderly Care News

Summary This document presents the Government’s response to the Science and Technology Select Committee’s “After the Storm?” report on blood safety. It sets out the government’s commitment to evidence-based and cost effective ways to reduce risks of infection from blood transfusions, … Continue reading →

Big Data and Public Health (Parliamentary Office of Science and Technology POST Note PN 474 / PN 468)

Posted on August 5, 2014 by Dementia and Elderly Care News

Summary This Parliamentary Office of Science & Technology (POST) note on “Big Data and Public Health” considers the growing use of patients’ health records and large-scale medical and administrative datasets as valuable sources of information for the study and improvement … Continue reading →

Posted in Commissioning, Department of Health, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), National, NHS, NHS England, Public Health England, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged Academic Research, Administrative Data, Administrative Data Research Network, Administrative Datasets, Aggregate Level Data Sources, Aggregated Data, Analytics, Anonymised Patient Medical Records, Applications of Big Data, Arts and Humanities Research Council, Avon Longitudinal Study of Parents & Children (ALSPAC), Be Clear on Cancer (BCOC), Big Data, Big Data Analytics, Big Data Funding and Research, Big Data Overview, Big Data: One of UK Government's Eight Great Technologies, Biotechnology and Biological Sciences Research Council, Care Act 2014, care.data, Care.data: Modern Data Service for the NHS, Clinical Audits, Clinical Commissioning Groups (CCGs), Clinical Practice Research Datalink (CPRD), Common Law Duty of Confidentiality, Data Extraction and Linkage, Data Linkage and Extract Service, Data Linkage to Support Surveillance, Data Protection Act (1998), Data Quality and Accuracy, Data Security and Identifiability, Data Security Techniques, Digital Care Records, Economic and Social Research Council, Eight Great Technologies, Electronic Care Records, Epidemiology, Epidemiology and Statistics, EU Data Protection Regulation, European Data Protection Regulation, Farr Institute, General Practice Extraction Service (GPES), Governance of Data Access, GPES Independent Advisory Group (IAG), Health and Social Care Act (2012), Health and Social Care Information Centre (HSCIC), Health Improvement, Health Informatics, Health Protection (Notification) Regulations 2010, Health Protection Agency, Health Service (Control of Patient Information) Regulations 2002, Healthcare Planning, Hospital Episode Statistics (HES), House of Commons Library, House of Commons Library POST Note PN 474, Human Rights Act (HRA), Increasing Efficiency, Informatics, Information Sharing, Innovation in Bioinformatics, Interoperability, Interoperability Standards, Legislation and Governance, Leveraging Big Data, Management of Big Data, Medical Informatics, Medical Research, National Cancer Data Repository, National Cancer Intelligence Network (NCIN), National Pupil Database, Natural Environment Research Council, NHS Electronic Patient Records, NHS Records, Office of National Statistics (ONS), Office of National Statistics Mortality Data, Office of Science & Technology POSTnote, Open Data, Open Data and Big Data, Open Data in Health and Social Care, Open Data in the NHS, Parliament, Parliamentary Office of Science & Technology, Parliamentary Office of Science & Technology (POST), Patient Records, Population Risk Stratification, POST Note PN 468, POST Note PN 474, POSTnote No.468, POSTnote No.474, POSTnotes, Primary Use Within the NHS, Pseudonymised Data, Public Health, Public Health and Health Improvement, Public Health England (PHE), Public Health Improvement, Public Health Informatics, Public Health Monitoring, Publicly-Funded UK Big Data Research, Records Management: NHS Code of Practice, Records Standards in Health and Social Care, Risk Stratification, Risk Stratification Programmes, Routes to Diagnosis (NCIN), Science and Technology Facilities Council, Secondary Use Beyond the NHS, Secondary Use Within the NHS, Secondary Uses Data Set, Secondary Uses Service (SUS), Social Epidemiology, Standardised Electronic Health Records, Summary Care Records, Summary Level Statistics, Transparency, Transparency and Accountability, Transparency and Open Data, Transparency and Public Trust, Use of Identifiable Records Without Consent: Section 251 of the National Health Service Act 2006, Uses of Data, Uses of Medical Records | Leave a comment

Tag Archives: Parliament

Minimising CJD and vCJD Transmission Risks in Healthcare and Community Settings (Department of Health)

Risks of Variant Creutzfeldt-Jakob Disease: UK Blood Safety (Department of Health)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites